Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving Understanding of Heroin Overdose Testing
2016-001877-34Phase 4Unknown
- Sponsor
- South London and Maudsley NHS Foundation Trust
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diamorphine in opioid use disorder (OUD) and opioid intoxication, sponsored by South London and Maudsley NHS Foundation Trust. Primary endpoint: Respiratory depression and hypoxemic response to high-dose diamorphine. Status: unknown.
02
Drugs
diamorphine
03
Conditions
opioid use disorder (OUD)opioid intoxication
Beyond the preview
Go deeper on 2016-001877-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001877-34.